關鍵數據
2.960今開
3.220最高
5.74K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.06%換手率
3.180昨收
2.960最低
9.35K成交額
虧損本益比靜
-6.36市淨率
0.00%股息率 TTM
--ROA
9.99052週最高
0.35量比
-1.53K淨利潤
9.06M總股本
-0.7311每股盈餘TTM
--Beta
--ROE
1.98052週最低
8.18%振幅
--毛利率
35.48M總市值
-1.39回報/風險
6.87%風險率
Nasus Pharma Ltd新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
技術指標
Nasus Pharma Ltd簡介
Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
公司代碼NSRX
公司Nasus Pharma Ltd
CEOTeleman (Dan)
網址https://www.nasuspharma.com
公司股東
常見問題
Nasus Pharma Ltd(NSRX)的當前股價是多少?
Nasus Pharma Ltd(NSRX)的當前股價是 3.20。
Nasus Pharma Ltd 的股票代碼是什麼?
Nasus Pharma Ltd的股票代碼是NSRX。
Nasus Pharma Ltd股票的52週最高點是多少?
Nasus Pharma Ltd股票的52週最高點是9.99。
Nasus Pharma Ltd股票的52週最低點是多少?
Nasus Pharma Ltd股票的52週最低點是1.98。
Nasus Pharma Ltd的市值是28.99M。
現在Nasus Pharma Ltd(NSRX)的股票是買入、持有還是賣出?
根據分析師評級,Nasus Pharma Ltd(NSRX)的總體評級為買入,目標價格為19.67。
Nasus Pharma Ltd(NSRX)股票的每股收益(EPS TTM)是多少
Nasus Pharma Ltd(NSRX)股票的每股收益(EPS TTM)是-0.73。